First Command Bank’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-300
Closed -$18K 516
2021
Q4
$18K Hold
300
﹤0.01% 331
2021
Q3
$18K Hold
300
﹤0.01% 331
2021
Q2
$20K Hold
300
﹤0.01% 323
2021
Q1
$21K Hold
300
﹤0.01% 301
2020
Q4
$23K Hold
300
0.01% 257
2020
Q3
$22K Hold
300
0.01% 236
2020
Q2
$19K Hold
300
0.01% 232
2020
Q1
$13K Hold
300
0.01% 253
2019
Q4
$14K Sell
300
-200
-40% -$9.46K 0.01% 290
2019
Q3
$23K Hold
500
0.01% 255
2019
Q2
$29K Hold
500
0.01% 246
2019
Q1
$22K Hold
500
0.01% 271
2018
Q4
$19K Hold
500
0.01% 282
2018
Q3
$23K Hold
500
0.01% 270
2018
Q2
$22K Hold
500
0.01% 282
2018
Q1
$19.8K Hold
500
0.01% 295
2017
Q4
$17K Sell
500
-800
-62% -$22.8K 0.01% 304
2017
Q3
$33K Hold
1,300
0.02% 236
2017
Q2
$22K Hold
1,300
0.01% 287
2017
Q1
$19K Hold
1,300
0.01% 284
2016
Q4
$18K Buy
+1,300
New +$20.1K 0.01% 289

First Command Bank's ARNA Position: Q1 2022 in Review

First Command Bank sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 300 shares — an estimated $18K sold.

First Command Bank first reported a position in ARNA in Q4 2016 and held it in 21 quarters. The position peaked at $33K in Q3 2017. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • First Command Bank reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • First Command Bank sold 300 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $18K.
  • First Command Bank first reported a position in Arena Pharmaceuticals Inc in Q4 2016 and held it in 21 quarters.
  • First Command Bank's Arena Pharmaceuticals Inc position peaked at $33K in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on First Command Bank's 13F filing for Q1 2022, filed 14 Apr 2022.